Disease Biomarkers

April 2015

News Highlight

Multiplex assays for profiling biomarkers in eye disease

Cytokines are important cell mediators in a variety of processes, including cancer, obesity, and many other processes where inflammation plays a role. A recent publication by Nassar et al. depicts the importance of serum cytokines as biomarkers for age-related macular degeneration.

In this post, our specialist Ana describes the technology used by this team.


Biomarkers of micronutrient malnutrition

Unfortunately, micronutrient malnutrition is a problem in all countries, in all segments of society. Tools to assess MN deficiencies are needed, allowing to screen large segments of population. 
Measuring of these markers is usually done by ELISA. This is a good method if you have enough sample, but what if you have to screen a large population?


For the next two months, tebu-bio puts the spotlight on antibodies for Cancer research by GeneTex. Take a look at the related offers below!

15% discount off Cancer research antibodies

Over 500 antibodies, as well as tissue slides and lysates for Cancer Research.

Choose two sample-size Cancer antibodies

Discover high quality research antibodies against proteins that are involved in cancer progression.
Choose your product & benefit from our discount... Try them at only 10 Euros for 10µl!

Current News

Tumour microenvironment – ameloblastomas

Ameloblastomas are benign tumours that occur in the jawbone, and invade bone. This type of tumour is treated by surgery and can cause various problems, including changes in facial countenance and mastication disorders. A recent publication  by Fuchigami et al.  has investigated the soluble factors (i.e. secretome) involved in the formation and progression of ameloblastoma..... Read more...

First Remicade® mAb biosimilar approved in Europe

"Following our series of posts in biosimilars and immunogenicity testing, a recent paper by Korea company Celltrion describes the characterisation of Remsina®, the first mAb biosimilar (for Remicade® – infliximab) approved in Europe. In this study, ELISA arrays for conformational studies were used for the Higher Order Structure characterisation and compatibility analysis." Read more...

Technical Corner

Diluting samples for proteomics – biomarker profiling case studies

To dilute or not to dilute biological samples? And if yes, how much? That’s the question! In this post, our specialist Ana discusses sample dilution (yes or no) and dilution factosr (how much) when performing proteomic analysis of Biomarkers.

Get the best of tebu-bio online!

Don't wait to explore our website, to fully benefit from everything tebu-bio brings you.
Find your reagents and services with our powerful search engine, order online, or get in in touch with one of our specialists straight away via our Live Chat function...
Take a tour today!

Our Quality Promise to you! 100% Satisfaction guaranteed, so you can get to work with peace of mind...

tebu-bio's newsletters cover many of your favourite research themes...

Follow us on Facebook Follow us on Twitter Follow us on LinkedIn Follow us on YouTube Google+ Google+